Molecular study of the proliferation process of beta cells derived from pluripotent stem cells

Mol Biol Rep. 2022 Feb;49(2):1429-1436. doi: 10.1007/s11033-021-06892-y. Epub 2021 Nov 3.

Abstract

Background: Diabetes mellitus (DM) is a chronic metabolic disorder, increasing in the number of patients and poses a severe threat to human health. Significant advances have been made in DM treatment; the most important of which is differentiation and proliferation of beta cells from IPSCs.

Methods: Data were collected from PUBMED at various time points up to the academic year of 2020. The related keywords are listed as follows: "Induced pluripotent stem cell", "Proliferation", "Growth factor", "Small molecule", "cardiotoxicity" and "Scaffold."

Result: The use of growth factors along with small molecules can be a good strategy for beta-cell proliferation. Also, proliferation of beta cells on nanofibers scaffolds can create a similar in vivo environment, that leads to increased function of beta-cell. Some transcription factors that cause beta cells proliferation play an important role in inflammation; so, it is essential to monitor them to prevent inflammation.

Conclusion: Finally, the simultaneous use of growth factors, micronutrients and scaffolds can be an excellent strategy to increase the proliferation and function of beta cells derived from IPSCs.

Keywords: Growth factor; Induced pluripotent stem cell; Proliferation; Scaffold; Small molecule.

Publication types

  • Review

MeSH terms

  • Cell Culture Techniques / methods*
  • Cell Differentiation / physiology
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Insulin / metabolism
  • Insulin-Secreting Cells / metabolism*
  • Insulin-Secreting Cells / physiology
  • Nanofibers / chemistry
  • Pluripotent Stem Cells / drug effects
  • Pluripotent Stem Cells / metabolism*
  • Tissue Engineering / methods
  • Tissue Scaffolds / chemistry

Substances

  • Insulin